Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HY.1ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
HY.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-2005.91Singapore
HY.1ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-2627.44Singapore
HY.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
HY.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
HY.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
HY.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
HY.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
HY.1ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-17292.3China
HY.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
HY.1ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
HY.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-2999.47Singapore
HY.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
HY.1SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
HY.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
HY.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
HY.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HY.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HY.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HY.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HY.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HY.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
HY.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-4914.61China
HY.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
HY.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
HY.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
HY.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
HY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HY.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HY.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
HY.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
HY.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
HY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HY.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
HY.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
HY.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HY.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
HY.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
HY.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
HY.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-893.215Hong Kong
HY.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
HY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HY.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HY.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HY.1ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-2242.74Japan
HY.1ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-25657.5Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used